EFM
WST icon

E Fund Management’s West Pharmaceutical WST Stock Holding History

E Fund Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$418K Sell
1,163
-393
-25% -$120K 0.01% 318
2026
Q1 		$390K Buy
+1,556
New +$387K 0.01% 335
2025
Q2 		$294K Sell
1,343
-135
-9% -$28.9K 0.01% 311
2025
Q1 		$331K Buy
1,478
+283
+24% +$78K 0.02% 295
2024
Q4 		$391K Buy
1,195
+478
+67% +$150K 0.02% 261
2024
Q3 		$215K Buy
717
+83
+13% +$25.4K 0.01% 314
2024
Q2 		$209K Buy
634
+21
+3% +$7.42K 0.01% 281
2024
Q1 		$243K Buy
+613
New +$227K 0.02% 307
2022
Q1 		– Sell
-445
Closed -$209K – 363
2021
Q4 		$209K Buy
+445
New +$192K 0.01% 252

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

E Fund Management's WST Position: Q2 2026 in Review

E Fund Management reduced its West Pharmaceutical (WST) stake by 25% in Q2 2026, selling an estimated $120K and leaving 1,163 shares worth $418K. The position accounts for 0.01% of the portfolio, ranked #318.

E Fund Management first reported a position in WST in Q4 2021 and has held it in 9 quarters since. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • E Fund Management held 1,163 shares of West Pharmaceutical worth $418K as of Q2 2026.
  • E Fund Management sold 393 West Pharmaceutical shares in Q2 2026, an estimated $120K.
  • West Pharmaceutical made up 0.01% of E Fund Management's portfolio in Q2 2026, its #318 holding.
  • E Fund Management first reported a position in West Pharmaceutical in Q4 2021 and has held it in 9 quarters since.
  • 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on E Fund Management's 13F filing for Q2 2026, filed 11 Aug 2026.